← Browse by Condition
Medical Condition

unresectable locally recurrent rectal cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06767007 Phase 2
Recruiting

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）

Enrollment
31 pts
Location
China
Sponsor
Sixth Affiliated Hospital, Sun...
View Trial →